United Therapeutics (UTHR) Tops Q3 EPS by 57c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $516.02 +1.48%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $4.16, $0.57 better than the analyst estimate of $3.59. Revenue for the quarter came in at $444.7 million versus the consensus estimate of $421.45 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
